GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apollomics Inc (NAS:APLMW) » Definitions » Sale Of Property, Plant, Equipment

APLMW (Apollomics) Sale Of Property, Plant, Equipment : $0.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Apollomics Sale Of Property, Plant, Equipment?

Apollomics's sale of property, plant, equipment for the six months ended in Jun. 2024 was $0.00 Mil. It means Apollomics gained $0.00 Mil from selling property, plant, and equipment. Apollomics's sale of property, plant, equipment for the trailing twelve months (TTM) ended in Jun. 2024 was $0.00 Mil.

Compared with last quarter ($0.00 Mil in Dec. 2023 ), Apollomics gained more money from selling property, plant, and equipment in Jun. 2024 ($0.00 Mil).


Apollomics Sale Of Property, Plant, Equipment Historical Data

The historical data trend for Apollomics's Sale Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apollomics Sale Of Property, Plant, Equipment Chart

Apollomics Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Sale Of Property, Plant, Equipment
- - - 0.06

Apollomics Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Sale Of Property, Plant, Equipment Get a 7-Day Free Trial - - - - -

Apollomics Sale Of Property, Plant, Equipment Calculation

The amount earned to sell PPE.

Sale Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Apollomics Sale Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of Apollomics's Sale Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.


Apollomics Business Description

Industry
Traded in Other Exchanges
Address
989 East Hillsdale Boulevard, Suite 220, Foster, CA, USA, 94404
Apollomics Inc is an innovative clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company lead programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.